ENCORE PHARMACY

Serial Number 98222773
730

Registration Progress

Application Filed
Oct 13, 2023
Under Examination
Sep 24, 2024
Approved for Publication
Jul 30, 2024
Published for Opposition
Jul 30, 2024
Registered

Basic Information

Serial Number
98222773
Deadline
September 24, 2025
Description
Statement of Use or 2nd Extension Due
Filing Date
October 13, 2023
Published for Opposition
July 30, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Mar 25, 2025
Application
Pending
Classes
035

Rights Holder

Founder Project Rx, Inc.

03
Address
5109 Oak Lane
Arlington, TX 76017

Ownership History

Founder Project Rx, Inc.

Original Applicant
03
Arlington, TX

Founder Project Rx, Inc.

Owner at Publication
03
Arlington, TX

Legal Representation

Attorney
Michelle M. Mikol
USPTO Deadlines 1 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUBE Aug 29, 2024 312 days overdue Medium Until Sep 29, 2024

Application History

19 events
Date Code Type Description
Apr 1, 2025 EISU I TEAS STATEMENT OF USE RECEIVED
Mar 25, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 25, 2025 EX1G S SOU EXTENSION 1 GRANTED
Mar 25, 2025 EXT1 S SOU EXTENSION 1 FILED
Mar 24, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 24, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 30, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 30, 2024 PUBO A PUBLISHED FOR OPPOSITION
Jul 10, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 26, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 12, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 12, 2024 GNRT F NON-FINAL ACTION E-MAILED
Jun 12, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 12, 2024 CNRT R NON-FINAL ACTION WRITTEN
Jun 12, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 12, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 31, 2024 DOCK D ASSIGNED TO EXAMINER
Oct 17, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 17, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 035
Retail pharmacy services

Active Deadlines

Notice of Publication
Due: Aug 29, 2024 Overdue

Classification

International Classes
035

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
PHARMACY